VOR

NASDAQ 已收盘

Vor Biopharma

18.52 USD
▲+0.69+3.87%
盘后 18.33 0.00%
2026-11-19
市值
$1.18B
市盈率
0.63
EPS
30.51
股息率
—
52 周区间
6.50 – 26.00
成交量
830.65K
Beta
1.83
目标价
38.97
52W 低 6.5052W 高 26.00
价格走势

公司简介

Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren’s disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and...

关联新闻